doxorubicin intravenous

TERMINATED · PHASE2, PHASE3 · Hepatocellular Carcinoma

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.